Please assess the completion status of the following clinical trial:

Trial Title: Fecal Microbiota Transplant (FMT) for Relapsing C. Difficile Infection in Adults and Children Using a Frozen Inoculum

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with recurrent or relapsing CDI defined as EITHER(13):~  * At least three episodes of mild-to-moderate CDI and failure of a 6-8 week taper with vancomycin with or without an alternative antibiotic (e.g. rifaximin, nitazoxanide).~ * At least two episodes of severe CDI resulting in hospitalization and associated with significant morbidity.~* Willingness to accept risk of unrelated donor stool~* Willingness to be randomized to NGT vs. colonoscopic delivery.~* Able to consent for self, or parental assent/child assent as age appropriate.~Exclusion Criteria:~* Anatomic contraindication to NGT~* Delayed gastric emptying syndrome~* Known chronic aspiration~* Contraindication to colonoscopy (ASA 4 or more)~* High risk of bacterial translocation (Immunosuppression, cirrhosis etc)~* Pregnant or breastfeeding women~* Acute unrelated infection or comorbid illness exaccerbation

- Gender: ALL
- Minimum Age: 7 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Colonoscopy (Type: EXPERIMENTAL): Fecal microbiota transplant (stool transplant) from healthy, unrelated donor via colonoscopy
- Nasogastric Tube (NGT) (Type: EXPERIMENTAL): Fecal microbiota transplant (stool transplant) from healthy, unrelated donor via NGT

Based on this trial design, predict the completion outcome and termination type (if applicable).